Delivery Order #75N91025F00016

Leidos Biomedical Multi-Year Delivery Order Boosts NCI Cancer Research

This award is a substantial multi-year delivery order contract granted to Leidos Biomedical Research, Inc., a subsidiary of Leidos Holdings, Inc., known for its biomedical research and development expertise. The contract supports the National Cancer Institute (NCI) by enhancing critical operational capabilities on NCI's Frederick, Maryland campus, which is vital for cancer research advancements. Under this agreement, Leidos Biomedical manages research infrastructure, procures and maintains specialized laboratory and scientific equipment, and oversees scientific projects that are pivotal to cancer research. The contract builds upon a prior indefinite delivery contract associated with the NCI Federally Funded Research and Development Center (FFRDC) program, demonstrating continued federal commitment to cancer research innovation. Awarded through competitive bidding, the contract guarantees transparent procurement of expert services essential to national health objectives. Key subcontractors include Vanderbilt University, contributing significant scientific research initiatives; the University of North Carolina at Chapel Hill, specializing in validating high-throughput screening assays; and the American Type Culture Collection, which manages vital central repository locations for research operations. Additional subcontractors provide essential maintenance and support for laboratory equipment, amplifying the contract's overall impact. The work spans from infrastructure management to scientific validation and equipment maintenance, embodying a comprehensive effort to propel cancer research forward. The contract's timeline covers several years, reflecting a long-term dedication to improving cancer research and public health outcomes.

Description

NCI OPERATIONAL TASK ORDER, FY26-FY27

View original record